FBXO45 is significantly overexpressed in T2E-positive PCA and is also associated with an unfavourable clinical course only in this subgroup, which further supports the subtype-specific consideration, especially concerning TMRPSS2–ERG fusion, in the development of robust prognostic biomarker models for PCA. This evidence concerns the gene ERG and posterior cortical atrophy.